Dataset: Immunotherapy Targets in Tumors
Recent work has shown that cytotoxic T cells play a central role in immune-mediated control of cancers1-3, and monoclonal antibodies that...
Recent work has shown that cytotoxic T cells play a central role in immune-mediated control of cancers1-3, and monoclonal antibodies that target inhibitory receptors on T cells can induce significant clinical benefit in patients despite advanced disease4-6. However, many of the regulatory pathways that result in loss of T cell function within immunosuppressive tumors remain unknown. Here we show that such regulatory mechanisms can be systematically discovered in vivo in the tumor microenvironment. We devised a pool shRNA screening approach aimed at identifying genes that block the function of tumor-infiltrating CD8 T cells. We postulated that shRNAs targeting key inhibitors would enable robust T cell infiltration and proliferation in tumors, despite multiple inhibitory signals. Candidate shRNAs were discovered by transfer of shRNA-transduced T cells into tumor-bearing mice, followed by deep sequencing to quantify the representation of all hairpins in tumors and lymphoid organs. A subset of shRNAs induced T cell accumulation in tumors but not the spleen, demonstrating feasibility of discovering shRNAs with differential action across tissues. One of the targets was Ppp2r2d, a regulatory subunit of the family of PP2A phosphatases7. Control shRNA-transduced T cells underwent apoptosis upon recognition of melanoma cells, while Ppp2r2d shRNA-transduced T cells accumulated in tumors due to enhanced proliferation and reduced apoptosis. Ppp2r2d shRNAexpressing T cells also significantly delayed tumor growth. This in vivo approach has wide applications to dissect complex immune functions in relevant tissue microenvironments. OT-I derived T cells were transduced with shRNA's and adoptively transferred to B16 tumor bearing mice. Following incubation the T cells were purified from either tumors or spleens. The shRNA's targeted either a control gene (LacZ) or one of 5 selected genes found to regulate the presence of T cells in tumors vs in spleen
- Species:
- mouse
- Samples:
- 36
- Source:
- E-GEOD-53388
- PubMed:
- 24476824
- Updated:
- Dec.12, 2014
- Registered:
- Nov.12, 2014
Sample | TRANSDUCTION | SAMPLE NAME | ORGANISM PART |
---|---|---|---|
GSM1290674 | shRNA targeting Lacz | 1-sp1 | spleen |
GSM1290675 | shRNA targeting Lacz | 1-sp2 | spleen |
GSM1290676 | shRNA targeting Lacz | 1-sp3 | spleen |
GSM1290677 | shRNA targeting Ppp2r2d | 2-sp1 | spleen |
GSM1290678 | shRNA targeting Ppp2r2d | 2-sp2 | spleen |
GSM1290679 | shRNA targeting Ppp2r2d | 2-sp3 | spleen |
GSM1290680 | shRNA targeting Egr2 | 3-sp1 | spleen |
GSM129068 | shRNA targeting Egr2 | 3-sp2 | spleen |
GSM1290682 | shRNA targeting Egr2 | 3-sp3 | spleen |
GSM1290683 | shRNA targeting Ptpn2 | 4-sp1 | spleen |
GSM1290684 | shRNA targeting Ptpn2 | 4-sp2 | spleen |
GSM1290685 | shRNA targeting Ptpn2 | 4-sp3 | spleen |
GSM1290686 | shRNA targeting Arhgap5 | 5-sp1 | spleen |
GSM1290687 | shRNA targeting Arhgap5 | 5-sp2 | spleen |
GSM1290688 | shRNA targeting Arhgap5 | 5-sp3 | spleen |
GSM1290689 | shRNA targeting Alk | 6-sp1 | spleen |
GSM1290690 | shRNA targeting Alk | 6-sp2 | spleen |
GSM129069 | shRNA targeting Alk | 6-sp3 | spleen |
GSM1290692 | shRNA targeting Lacz | 1-tu1 | Tumor |
GSM1290693 | shRNA targeting Lacz | 1-tu2 | Tumor |
GSM1290694 | shRNA targeting Lacz | 1-tu3 | Tumor |
GSM1290695 | shRNA targeting Ppp2r2d | 2-tu1 | Tumor |
GSM1290696 | shRNA targeting Ppp2r2d | 2-tu2 | Tumor |
GSM1290697 | shRNA targeting Ppp2r2d | 2-tu3 | Tumor |
GSM1290698 | shRNA targeting Egr2 | 3-tu1 | Tumor |
GSM1290699 | shRNA targeting Egr2 | 3-tu2 | Tumor |
GSM1290700 | shRNA targeting Egr2 | 3-tu3 | Tumor |
GSM129070 | shRNA targeting Ptpn2 | 4-tu1 | Tumor |
GSM1290702 | shRNA targeting Ptpn2 | 4-tu2 | Tumor |
GSM1290703 | shRNA targeting Ptpn2 | 4-tu3 | Tumor |
GSM1290704 | shRNA targeting Arhgap5 | 5-tu1 | Tumor |
GSM1290705 | shRNA targeting Arhgap5 | 5-tu2 | Tumor |
GSM1290706 | shRNA targeting Arhgap5 | 5-tu3 | Tumor |
GSM1290707 | shRNA targeting Alk | 6-tu1 | Tumor |
GSM1290708 | shRNA targeting Alk | 6-tu2 | Tumor |
GSM1290709 | shRNA targeting Alk | 6-tu3 | Tumor |